ResMed Inc. Form 8-K Summary
Business Context and Reporting Period
ResMed Inc. (NYSE: RMD) filed a Current Report on Form 8-K on January 29, 2026. The filing primarily reports the results of operations for the quarter ended December 31, 2025, and announces a new quarterly cash dividend.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing the detailed results of operations for the quarter ended December 31, 2025. However, the text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes and Corporate Actions
- Dividend Declaration: The Board of Directors declared a quarterly cash dividend of US $0.60 per share.
- Dividend Schedule:
- Record Date: February 12, 2026
- Payment Date: March 19, 2026
- Ex-Dividend Date: February 11, 2026
- Currency and CDI Terms: Dividends are paid in U.S. currency to NYSE holders. Holders of CHESS Depositary Instruments (CDIs) on the Australian Securities Exchange will receive an equivalent amount in Australian currency based on the exchange rate on the record date, reflecting a 10:1 ratio between CDIs and NYSE shares.
- ASX Waiver: ResMed received a waiver from ASX settlement rules to defer processing conversions between common stock and CDI registers from February 11, 2026, through February 12, 2026.
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, forward-looking guidance, risk factors, or contingencies regarding the quarter's performance. It explicitly states that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 2025 revenue, earnings, and cash flow figures.
- Verify the ex-dividend date of February 11, 2026, for trade settlement purposes.
- Confirm the 10:1 conversion ratio for CDI holders receiving dividends in Australian currency.
- Check for any updated full-year 2025 guidance within the attached press release.